Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study.
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000627:therapeutic use; D000704:Analysis of Variance; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales
D000873:Anthracenes; D000928:Antidepressive Agents; D011437:Propylamines; D000639:Amitriptyline; D007099:Imipramine